HSG
CVS icon

Helen Stephens Group’s CVS Health CVS Stock Holding History

Helen Stephens Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,198
Closed -$248K – 90
2024
Q2 		$248K Hold
4,198
– – 0.09% 73
2024
Q1 		$335K Buy
4,198
+443
+12% +$33.8K 0.13% 56
2023
Q4 		$296K Sell
3,755
-20
-0.5% -$1.42K 0.13% 58
2023
Q3 		$264K Hold
3,775
– – 0.14% 56
2023
Q2 		$261K Buy
3,775
+37
+1% +$2.63K 0.13% 56
2023
Q1 		$278K Hold
3,738
– – 0.14% 60
2022
Q4 		$348K Sell
3,738
-170
-4% -$16.4K 0.21% 56
2022
Q3 		$373K Buy
3,908
+435
+13% +$43.1K 0.26% 46
2022
Q2 		$322K Buy
3,473
+8
+0.2% +$781 0.23% 44
2022
Q1 		$351K Sell
3,465
-151
-4% -$15.9K 0.24% 41
2021
Q4 		$373K Buy
+3,616
New +$334K 0.3% 36

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Helen Stephens Group's CVS Position: Q3 2024 in Review

Helen Stephens Group sold out of CVS Health (CVS) in Q3 2024, closing a stake of 4,198 shares — an estimated $248K sold.

Helen Stephens Group first reported a position in CVS in Q4 2021 and held it in 11 quarters. The position peaked at $373K in Q3 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Helen Stephens Group reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Helen Stephens Group sold 4,198 CVS Health shares in Q3 2024, an estimated $248K.
  • Helen Stephens Group first reported a position in CVS Health in Q4 2021 and held it in 11 quarters.
  • Helen Stephens Group's CVS Health position peaked at $373K in Q3 2022.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Helen Stephens Group's 13F filing for Q3 2024, filed 8 Oct 2024.